Sangamo Therapeutics, Inc: Form 8-K, filed Sep 21, 2026
Filed with the SEC on Sep 21, 2026 and accepted by EDGAR at Sep 21, 2026, 16:01 ET.
Items reported
- Item 1.03 Bankruptcy or receivership
- Item 2.01 Completion of an acquisition or disposition
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-396644. Last ingested by Listed: Oct 27, 2026, 16:02 ET. Listed shows no prices and gives no investment advice.